Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics designed to restore synapses to improve the lives of patients, will present this week the results of ...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that it will deliver more than 40 scientific data ...
VANCOUVER, BC, April 20, 2026 — Dr. Della Chow, founder of Della Optique in Kitsilano, is calling on British Columbia ...
The company is prioritising improvements in product quality alongside the expansion and diversification of its production ...
At 2 years, trabecular micro-bypass implantation in combination with phacoemulsification yielded IOP reductions in patients ...
Pharco Pharmaceuticals launched its "Vision for All" initiative to advance ophthalmic healthcare services across Egypt and ...
Press Release Nicox Provides Full Year 2025 Financial Results and Corporate UpdateRevenue of €16.8 million (€7.9 million in 2024) Net loss ...
Q3 2026 Earnings Call May 4, 2026 9:30 PM EDTCompany ParticipantsMark Flynn - Investor RelationsThomas Spurling - MD ...
Dr. Jeffrey Levenson has shared a detailed guide on cataract surgery, explaining when it’s needed, available surgical methods, lens choices, recovery timelines, and potential complications. He ...
NR3C1 encodes the glucocorticoid receptor (GR) and regulates stress responses, metabolism, immune function, and inflammation, ...
India Currents on MSN
Understanding early stage glaucoma
Manvinder’s story Manvinder*, a 62-year-old college professor from Minnesota, went for a routine eye examination. His ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results